Profile data is unavailable for this security.
About the company
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
- Revenue in USD (TTM)2.06m
- Net income in USD-19.80m
- Incorporated2004
- Employees69.00
- LocationFemasys Inc3950 JOHNS CREEK COURT, SUITE 100SUWANEE 30024United StatesUSA
- Phone+1 (770) 500-3910
- Websitehttps://www.femasys.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jin Medical International Ltd | 22.83m | 1.79m | 22.26m | 269.00 | 12.42 | 0.7975 | 11.28 | 0.9752 | 0.0115 | 0.0115 | 0.1458 | 0.1783 | 0.509 | 3.26 | 4.15 | 84,857.36 | 3.85 | 10.68 | 6.34 | 16.51 | 35.79 | 34.53 | 7.55 | 13.92 | 1.90 | -- | 0.3617 | 0.00 | 18.57 | 2.90 | 27.71 | 0.1554 | 96.27 | -- |
| Inspira Technologies Oxy BHN Ltd | 289.00k | -11.21m | 23.22m | 38.00 | -- | 14.57 | -- | 80.33 | -0.4606 | -0.4606 | 0.0128 | 0.0446 | 0.0417 | 0.5281 | 0.6659 | 7,605.26 | -161.61 | -109.16 | -302.02 | -145.38 | 0.692 | -- | -3,879.24 | -- | 0.9002 | -- | 0.00 | -- | -- | -- | 2.06 | -- | 39.54 | -- |
| Global Innovative Platforms Inc | 0.00 | -718.26k | 23.84m | 52.00 | -- | 120.87 | -- | -- | -0.0179 | -0.0179 | 0.00 | 0.0042 | 0.00 | -- | -- | -- | -720.78 | -- | -929.61 | -- | -- | -- | -- | -- | -- | -- | 0.0079 | -- | -- | -- | -427.35 | -- | -- | -- |
| IRIDEX Corp | 50.65m | -5.09m | 24.58m | 93.00 | -- | -- | -- | 0.4854 | -0.3026 | -0.3026 | 3.02 | 0.2746 | 1.73 | 3.43 | 7.74 | 544,591.40 | -17.39 | -20.28 | -33.62 | -29.96 | 38.18 | 42.41 | -10.04 | -15.17 | 1.35 | -- | 0.4418 | -- | -6.17 | 2.30 | 6.90 | -- | -36.71 | -- |
| Femasys Inc | 2.06m | -19.80m | 28.36m | 69.00 | -- | 5.04 | -- | 13.76 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| PetVivo Holdings Inc | 1.41m | -9.65m | 28.54m | 24.00 | -- | 6.70 | -- | 20.26 | -0.402 | -0.402 | 0.0592 | 0.1269 | 0.3337 | 0.6261 | 10.37 | 58,701.67 | -224.88 | -195.28 | -343.15 | -346.33 | 78.88 | 74.58 | -673.99 | -1,163.49 | 1.45 | -4.23 | 0.00 | -- | 16.91 | 216.08 | 23.33 | -- | 49.21 | -- |
| Wellgistics Health Inc | 34.08m | -77.75m | 28.58m | 31.00 | -- | 4.20 | -- | 0.8386 | -1.32 | -1.32 | 0.6161 | 0.0758 | 0.629 | 3.63 | 17.53 | -- | -143.52 | -- | -365.21 | -- | 7.86 | -- | -228.17 | -- | 0.1628 | -16.42 | 0.7854 | -- | -- | -- | -136.77 | -- | -- | -- |
| Myomo Inc | 41.64m | -12.02m | 29.71m | 184.00 | -- | 2.03 | -- | 0.7136 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Vivos Inc | 48.63k | -3.01m | 30.85m | 10.00 | -- | 14.15 | -- | 634.36 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 31.76m | 61.00 | -- | 2.54 | -- | 2.15 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| Vaso Corp | 89.11m | 2.59m | 32.55m | 298.00 | 12.60 | 1.15 | 9.82 | 0.3653 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 33.23m | 143.00 | -- | 0.675 | -- | 1.04 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Guided Therapeutics Inc | 178.00k | -2.80m | 33.43m | 4.00 | -- | -- | -- | 187.82 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Modular Medical Inc | 0.00 | -24.22m | 34.33m | 54.00 | -- | 3.08 | -- | -- | -0.5081 | -0.5081 | 0.00 | 0.1434 | 0.00 | -- | -- | 0.00 | -222.79 | -171.42 | -294.38 | -207.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.75 | -- | 57.07 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 34.85m | 10.00 | -- | 4.31 | -- | 37.55 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to Femasys Inc's reporting currency: US Dollar USD
6.52%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dauntless Investment Group LLCas of 30 Sep 2025 | 1.73m | 2.91% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.17m | 1.96% |
| Geode Capital Management LLCas of 30 Sep 2025 | 258.23k | 0.43% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 249.88k | 0.42% |
| Clear Creek Financial Management LLCas of 31 Dec 2025 | 109.66k | 0.18% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 94.06k | 0.16% |
| UBS Securities LLCas of 31 Dec 2025 | 90.91k | 0.15% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 75.36k | 0.13% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 56.37k | 0.10% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2025 | 47.06k | 0.08% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
